派格生物医药（苏州）股份有限公司
Investors 1
| Date | Name | Website |
| - | ShareLink ... | sharelink-... |
Mentions in press and media 2
| Date | Title | Description |
| 19.08.2025 | Innogen bets on longer-lasting GLP-1 drugs to stand out in crowded field | On August 15, Innogen, a pharmaceutical company focused on glucagon-like peptide-1 (GLP-1) therapies, debuted on the Hong Kong Stock Exchange. The company’s shares surged as much as 300% intraday and closed up 200%, pushing its market capit... |
| 07.12.2020 | Chinese biopharma firm developing diabetes drugs raises $122 million in lead-up to IPO |